Loading clinical trials...
Loading clinical trials...
Evaluation of a Cognitive Remediation Program on Patients With Bipolar Disorders, With Memory Complaints
Bipolar disorder is a major health concern. Intercritical periods are marked with residual symptoms, both thymic and cognitive, which affects quality of life of patients, but also the quality of observance. The implementation of cognitive remediation programs could be interesting. The aim of this study is to evaluate the overall performance on euthymic bipolar patients with memory complaints included in the program named "COGMED", targeting the working memory. The impact of this program on compliance, quality of life, and memory complaints will be evaluated. The investigator will measure whether there is a correlation between working memory and overall performances. Finally, the investigator will try to achieve a profile of bipolar patients in whom the Cogmed program is particularly effective on a plan of overall performance.
Patients with bipolar disorder and memory complaints will be recruited. Two visits : 1. at baseline (V0) : the investigator evaluate bipolar disorder, treatment, mood, quality of life, global functioning, and memory complaints. Patients also have a neuropsychological assessment. The COGMED program is proposed to patients with memory complaints and explain by the investigator 2. 4-6 weeks after the end of the program (11-13 weeks after V1) : the same evaluation is realized to compare score before and after the program of cognitive remediation. Between the two visits the patient will benefit of COGMED program, at home, during 5 weeks. COGMED is a remediation cognitive program, based on working memory, consisting on daily exercises at home on a computer.
Age
1 - 65 years
Sex
ALL
Healthy Volunteers
No
Montpellier University Hospital
Montpellier, France
Start Date
July 1, 2014
Primary Completion Date
November 1, 2017
Completion Date
November 1, 2017
Last Updated
December 9, 2016
41
ESTIMATED participants
COGMED program
BEHAVIORAL
Lead Sponsor
University Hospital, Montpellier
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions